{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T05:12:21Z","timestamp":1738041141445,"version":"3.33.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clinbiochem.2024.110827","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T05:48:16Z","timestamp":1726724896000},"page":"110827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diagnostic value of serum GDF-15 in patients with pseudomyxoma peritonei"],"prefix":"10.1016","volume":"133-134","author":[{"given":"Bing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guowei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2024.110827_b0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4240\/wjgs.v10.i5.49","article-title":"Approach to pseudomyxoma peritonei","volume":"10","author":"Rizvi","year":"2018","journal-title":"World J. Gastrointest. Surg."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0010","unstructured":"Yu B, Raj MS. Pseudomyxoma Peritonei. In: StatPearls. Treasure Island (FL): StatPearls Publishing; March 27, 2024."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/02656736.2017.1310938","article-title":"Pseudomyxoma peritonei: natural history and treatment","volume":"33","author":"Mittal","year":"2017","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3892\/etm.2013.1408","article-title":"Clinicopathological features and prognosis of pseudomyxoma peritonei","volume":"7","author":"Wang","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0025","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","article-title":"Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy","volume":"36","author":"Elias","year":"2010","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0030","first-page":"1527","article-title":"Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"99","author":"Li","year":"2019","journal-title":"Natl Med J China"},{"issue":"10","key":"10.1016\/j.clinbiochem.2024.110827_b0035","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.ejso.2022.06.013","article-title":"Prevalence and incidence of pseudomyxoma peritonei in urban China: A nationwide retrospective cohort study","volume":"48","author":"Feng","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110827_b0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.12998\/wjcc.v12.i2.361","article-title":"Asymptomatic low-grade appendiceal mucinous neoplasm: A case report","volume":"12","author":"Yao","year":"2024","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.clinbiochem.2024.110827_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2024.109716","article-title":"Mucinous appendiceal neoplasms: report of a case and brief literature review","volume":"119","author":"D'Amata","year":"2024","journal-title":"Int. J. Surg. Case Rep."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.594763","article-title":"Prognostic value of CEA, CA19-9, CA125, CA724, and CA242 in serum and ascites in pseudomyxoma peritonei","volume":"11","author":"Liang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2016.02.022","article-title":"Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei","volume":"54","author":"Nummela","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0060","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1007\/s11605-021-04953-y","article-title":"The utility of preoperative tumor markers in peritoneal carcinomatosis from primary appendiceal adenocarcinoma: an analysis from the US HIPEC collaborative","volume":"25","author":"Fackche","year":"2021","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/08977194.2011.607137","article-title":"The TGF-\u03b2 superfamily cytokine, MIC-1\/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism","volume":"29","author":"Breit","year":"2011","journal-title":"Growth Factors"},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110827_b0070","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/cancers16071406","article-title":"Progress in Biological Research and Treatment of Pseudomyxoma Peritonei","volume":"16","author":"Li","year":"2024","journal-title":"Cancers (basel)."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/10408363.2019.1615034","article-title":"Growth differentiation factor 15: a novel biomarker with high clinical potential","volume":"56","author":"Desmedt","year":"2019","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0080","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3389\/fphys.2018.01712","article-title":"GDF15 and growth control","volume":"9","author":"Emmerson","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0085","first-page":"951","article-title":"Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Font Immunol"},{"key":"10.1016\/j.clinbiochem.2024.110827_b0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/pcan.2012.6","article-title":"Growth\/differentiation factor-15: prostate cancer suppressor or promoter?","volume":"15","author":"Va\u0148hara","year":"2012","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110827_b0095","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.21037\/tlcr-23-548","article-title":"Serum-based biomarkers associated with lung cancer risk and cause-specific mortality in the German randomized Lung Cancer Screening Intervention (LUSI) trial","volume":"12","author":"Cort\u00e9s-Ib\u00e1\u00f1ez","year":"2023","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.clinbiochem.2024.110827_b0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","article-title":"Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia","volume":"64","author":"Siddiqui","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0105","doi-asserted-by":"crossref","first-page":"1295228","DOI":"10.3389\/fonc.2023.1295228","article-title":"Growth differentiation factor 15 (GDF15) elevation in children with newly diagnosed cancer","volume":"13","author":"Runco","year":"2023","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2024.110827_b0110","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.jtha.2023.04.043","article-title":"Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study","volume":"21","author":"Nopp","year":"2023","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110827_b0115","doi-asserted-by":"crossref","first-page":"e36594","DOI":"10.1097\/MD.0000000000036594","article-title":"Growth differentiation factor-15 may be a novel biomarker in pancreatic cancer: A review","volume":"103","author":"Guo","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110827_b0120","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1111\/cas.15869","article-title":"Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer","volume":"114","author":"Wang","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.clinbiochem.2024.110827_b0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0135","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3233\/CBM-170792","article-title":"Growth\/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer","volume":"21","author":"Vocka","year":"2018","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3233\/CBM-170203","article-title":"Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass","volume":"21","author":"Hogendorf","year":"2018","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0145","unstructured":"National Health and Health Commission of the people\u2019s Republic of China. Reference intervals for common clinical immunology tests: Part 2. Non-book Materials: WS\/T 645. 2-2018 [S]. Beijing: Standards Press of China, 2018. (in Chinese)."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0150","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110827_b0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-1119(99)00309-1","article-title":"Characterization of the rat, mouse, and human genes of growth\/differentiation factor-15\/macrophage inhibiting cytokine-1 (GDF-15\/MIC-1)","volume":"237","author":"B\u00f6ttner","year":"1999","journal-title":"Gene"},{"issue":"3\u20134","key":"10.1016\/j.clinbiochem.2024.110827_b0160","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/08977194.2019.1685988","article-title":"Growth differentiation factor 15 and its role in carcinogenesis: an update","volume":"37","author":"Modi","year":"2019","journal-title":"Growth Factors"},{"issue":"10","key":"10.1016\/j.clinbiochem.2024.110827_b0165","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-05-4067","article-title":"Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer","volume":"66","author":"Bauskin","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/2211-5463.12537","article-title":"Utility of GDF-15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and Meta-Analysis","volume":"9","author":"Liu","year":"2018","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.clinbiochem.2024.110827_b0175","first-page":"3749","article-title":"Research on values of GDF-15 level in the diagnosis of primary liver cancer and evaluation of chemotherapeutic effect","volume":"22","author":"Shen","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/ijms20010163","article-title":"Inhibition of breast cancer cell invasion by ras suppressor-1 (RSU-1) silencing is reversed by growth differentiation factor-15 (GDF-15)","volume":"20","author":"Gkretsi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0185","doi-asserted-by":"crossref","first-page":"e13168","DOI":"10.1111\/eci.13168","article-title":"GDF-15 in solid vs non-solid treatment-na\u00efve malignancies","volume":"49","author":"Arfsten","year":"2019","journal-title":"Eur. J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110827_b0190","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/carcin\/bgi031","article-title":"The macrophage inhibitory cytokine integrates AKT\/PKB and MAP kinase signaling pathways in breast cancer cells","volume":"26","author":"Wollmann","year":"2005","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110827_b0195","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13046-018-0744-0","article-title":"GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1\/2 through the receptor ErbB2","volume":"37","author":"Li","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.clinbiochem.2024.110827_b0200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pharmthera.2019.02.008","article-title":"Growth differentiation factor 15 (GDF15): a survival protein with therapeutic potential in metabolic diseases","volume":"198","author":"Baek","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110827_b0205","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/carcin\/bgn031","article-title":"Macrophage inhibitory cytokine-1 activates AKT and ERK-1\/2 via the transactivation of ErbB2 in human breast and gastric cancer cells","volume":"29","author":"Kim","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.clinbiochem.2024.110827_b0210","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s11596-021-2335-0","article-title":"GDF-15 level correlates with CMKLR1 and VEGF-A in tumor-free margin in colorectal cancer","volume":"41","author":"Mielcarska","year":"2021","journal-title":"Curr Med Sci"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110827_b0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12885-023-10545-7","article-title":"Serum and ascites tumor markers in the diagnostic and prognostic prediction for appendiceal pseudomyxoma peritonei","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024001218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024001218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T04:53:32Z","timestamp":1737953612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912024001218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":43,"alternative-id":["S0009912024001218"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110827","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic value of serum GDF-15 in patients with pseudomyxoma peritonei","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"110827"}}